BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BioTonix: Annual and Special Meeting of Shareholders


6/8/2010 9:43:45 AM

BOUCHERVILLE, QUEBEC--(Marketwire - June 08, 2010) - Biotonix (2010) Inc. (TSX VENTURE: BTX) ("Biotonix"), a leader in postural health and fitness, announced today agenda details of its annual and special meeting of shareholders:


DATE:          Wednesday, June 16, 2010                
                                                       
TIME:          10:00 am to noon EST                    
                                                       
PLACE:         Sheraton Centre Montreal                
               1201 Rene-Levesque W., Montreal, H3B 2L7
               Ballroom centre                         

AGENDA

Brian Edwards, Chairman of the Board of Directors, will host the formal segment of the meeting. Louise St-Onge, CEO, will present the company as well as an overview of activities and the 2010-2012 outlook.

After this presentation, Dr. Sylvain Guimond, D.O., Ph.D., President, and Daniel Langevin, CPGA, Head Coach of AGP's sport-etudes program (Association des golfeurs professionnels du Quebec), University of Montreal's Carabins-Golf and Golf Performance Academy, will officially launch Biotonix's personalized postural assessment solution for golf. In addition, they will conduct a live GolfPrint™ evaluation and feature a testimonial from Mario Lemieux following the product's trial in Tremblant. The product's microsite, www.GolfPrint.ca, will be unveiled at that moment.

ABOUT BIOTONIX

Biotonix (TSX VENTURE: BTX) offers innovative health solutions for posture correction and fitness using a web-based imaging software technology. Biotonix is currently developing novel orthotics for the back and foot, also geared specifically toward improving posture. For more information please visit www.biotonix.com.

BIOTONIX'S FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. There is a risk that expectations and forward looking statements will not prove to be accurate. Readers are cautioned not to place undue reliance on these forward looking statements as they involve risks and uncertainties, which could make actual results differ materially from those projected herein and depend on a number of factors including, but not limited to, no history of profitability, future financing, intellectual property and patents, key personnel, competitive marketplace, technology obsolescence, share price volatility and other risks detailed from time to time in the Company's filings. While Biotonix anticipates that subsequent events and developments may cause its views to change, Biotonix specifically disclaims any obligation to update these forward looking statements, unless obligated to do so by applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Contacts:
Biotonix
Louise St-Onge
CEO
514-840-0004 ext 229

Biotonix
Julie M. Thibodeau, B.Sc., MBA
VP, Corporate Communications and Investor Relations
514-840-0004 ext 223
thibodeauj@biotonix.com
www.biotonix.com



Read at BioSpace.com

BioTonix
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES